Circulation, Vol 76, 508-514, Copyright © 1987 by American Heart Association
D Steinberg
It is now clear that hypercholesterolemia can, in some instances, be a
necessary and sufficient cause of premature atherosclerosis. This has been
best established in patients with familial hypercholesterolemia, a
deficiency of the low-density lipoprotein receptor. Although
hypercholesterolemia is not the only cause of atherosclerosis, a large body
of evidence has identified it as a determining cause in many cases. This
article reviews current hypotheses regarding the mechanisms by which
hypercholesterolemia accelerates atherogenesis. The role of the foam cell
is discussed in detail because it is a characteristic feature of the
earliest lesion, the so-called fatty streak. Once thought to derive
exclusively from smooth muscle cells, the foam cell is now known to
originate in large part from monocytes that enter the artery wall and alter
their properties to become tissue macrophages. Recent studies of the
biology of the macrophage-derived foam cell are providing new insights into
the mechanisms by which it enters the arterial wall and interacts with
various classes of native and modified lipoproteins. As our understanding
of the biology of the foam cell and its precursors grows, it may become
possible to intervene and slow the progress of atherosclerosis by new
modalities that might act synergistically with measures to control plasma
cholesterol levels.
ARTICLES
Lipoproteins and the pathogenesis of atherosclerosis
This article has been cited by other articles:
![]() |
C. Hu, A. Dandapat, L. Sun, J. Chen, M. R. Marwali, F. Romeo, T. Sawamura, and J. L. Mehta LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet Cardiovasc Res, July 15, 2008; 79(2): 287 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cassol, M. Alfano, P. Biswas, and G. Poli Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence J. Leukoc. Biol., November 1, 2006; 80(5): 1018 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Scholz, W. Sandberg, J. K. Damas, C. Smith, A. K. Andreassen, L. Gullestad, S. S. Froland, A. Yndestad, P. Aukrust, and B. Halvorsen Enhanced Plasma Levels of LIGHT in Unstable Angina: Possible Pathogenic Role in Foam Cell Formation and Thrombosis Circulation, October 4, 2005; 112(14): 2121 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. De Souza and N. I. Williams Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women Hum. Reprod. Update, September 1, 2004; 10(5): 433 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Lindstedt, M. J. Leskinen, and P. T. Kovanen Proteolysis of the Pericellular Matrix: A Novel Element Determining Cell Survival and Death in the Pathogenesis of Plaque Erosion and Rupture Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1350 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Boyanovsky, A. Karakashian, K. King, N. Giltiay, and M. Nikolova-Karakashian Uptake and Metabolism of Low Density Lipoproteins with Elevated Ceramide Content by Human Microvascular Endothelial Cells: IMPLICATIONS FOR THE REGULATION OF APOPTOSIS J. Biol. Chem., July 11, 2003; 278(29): 26992 - 26999. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ferro, S. Parrotto, S. Basili, C. Alessandri, and F. Violi Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia J. Am. Coll. Cardiol., August 1, 2000; 36(2): 427 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Feng, J. Han, S. F. A. Pearce, R. L. Silverstein, A. M. Gotto , Jr., David. P. Hajjar, and A. C. Nicholson Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-{gamma} J. Lipid Res., May 1, 2000; 41(5): 688 - 696. [Abstract] [Full Text] |
||||
![]() |
J. Han, D. P. Hajjar, J. M. Tauras, J. Feng, A. M. Gotto Jr., and A. C. Nicholson Transforming Growth Factor-beta 1 (TGF-beta 1) and TGF-beta 2 Decrease Expression of CD36, the Type B Scavenger Receptor, through Mitogen-activated Protein Kinase Phosphorylation of Peroxisome Proliferator-activated Receptor-gamma J. Biol. Chem., January 14, 2000; 275(2): 1241 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Massaeli, C. Hurtado, J. A. Austria, and G. N. Pierce Oxidized low-density lipoprotein induces cytoskeletal disorganization in smooth muscle cells Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2017 - H2025. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sakotnik, P.M. Liebmann, K. Stoschitzky, P. Lercher, K. Schauenstein, W. Klein, and B. Eber Decreased melatonin synthesis in patients with coronary artery disease Eur. Heart J., September 2, 1999; 20(18): 1314 - 1317. [Abstract] [PDF] |
||||
![]() |
J. Han, D. P. Hajjar, J. M. Tauras, and A. C. Nicholson Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36 J. Lipid Res., May 1, 1999; 40(5): 830 - 838. [Abstract] [Full Text] |
||||
![]() |
T. J. Kalogeris, C. G. Kevil, F. S. Laroux, L. L. Coe, T. J. Phifer, and J. S. Alexander Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L9 - L19. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schrott, A. G. Fereshetian, R. H. Knopp, H. Bays, P. H. Jones, T. W. Littlejohn, R. McLain, and D. M. Black A Multicenter, Placebo-Controlled, Dose-Ranging Study of Atorvastatin Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(2): 119 - 123. [Abstract] [PDF] |
||||
![]() |
J. Han, D. P. Hajjar, M. Febbraio, and A. C. Nicholson Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36 J. Biol. Chem., August 22, 1997; 272(34): 21654 - 21659. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Catalano, E. Perilli, G. Carzaniga, G. Scandale, and M. Carotta Arterial Damage, Triglycerides, Apolipoprotein, and Lp-(a) Values in PVD Patients Clinical and Applied Thrombosis/Hemostasis, April 1, 1997; 3(2): 104 - 109. [Abstract] [PDF] |
||||
![]() |
A. C. Nicholson, S. Frieda, A. Pearce, and R. L. Silverstein Oxidized LDL Binds to CD36 on Human Monocyte-Derived Macrophages and Transfected Cell Lines : Evidence Implicating the Lipid Moiety of the Lipoprotein as the Binding Site Arterioscler Thromb Vasc Biol, February 1, 1995; 15(2): 269 - 275. [Abstract] [Full Text] |
||||
![]() |
J. C Grotta Prevention and management of stroke Vascular Medicine, March 1, 1991; 2(1): 3 - 17. [PDF] |
||||
![]() |
M. FISHER, P. H. LEVINE, and A. LEAF n-3 Fatty Acids and Cellular Aspects of Atherosclerosis Arch Intern Med, August 1, 1989; 149(8): 1726 - 1728. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |